Anterix CFO Awarded RSUs Valued at ~$257K as Compensation
Anterix Inc.
Subscribe to track ATEX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Anterix CFO Awarded RSUs Valued at ~$257K
Company: Anterix Inc. (ATEX) Form: 4 | Filed: 2025-11-04 Significance: Low
Insider: Marquez Elena Title: Chief Financial Officer | Relationship: Officer
Transaction (Grant): • Type: Grant (RSUs) • Shares: 11,405 • Price: $0.00 • Value: $0 (Notional value ~$257k) • Owned After: 18,029
Key Insight: The CFO received a routine grant of Restricted Stock Units as part of their compensation. The transaction is non-discretionary and has low market significance.
Market Context: The grant represents ~0.06% of shares outstanding, a minor potential dilution. A separate transaction shows 404 shares were withheld for taxes from a prior vesting.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Anterix Inc. (ATEX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Financial Officer received a routine Restricted Stock Unit (RSU) grant as part of a standard compensation package.
- Market Impact: Minimal. This is a non-discretionary event and does not signal a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Anterix Inc. |
| Ticker Symbol | ATEX |
| CIK | 0001304492 |
| Industry | Telephone Communications |
Insider Information
| Field | Value |
|---|---|
| Name | Marquez Elena |
| CIK | 0002090789 |
| Title/Position | Chief Financial Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-09-29 |
| Transaction Code | A (Award) |
| Security Type | Common Stock (RSUs) |
| Shares Involved | 11,405 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 18,029 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Notional value of ~$257,183 based on a price of $22.55) |
| % of Market Cap | ~0.07% |
| Shares Transacted | 11,405 |
| % of Shares Outstanding | ~0.06% |
| Post-Transaction Ownership | 18,029 shares (~0.10% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The grant's notional value is insignificant compared to Anterix's $380 million market capitalization.
- Ownership Concentration: The CFO's total holdings remain minor at approximately 0.10% of the company's outstanding shares.
- Dilution Impact: The grant represents a potential future dilution of ~0.06%, which is negligible for current shareholders.
- Transaction Significance: As a standard equity compensation grant, this transaction is considered routine and carries low significance. It is not an open-market trade reflecting the insider's investment decision.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a scheduled compensation award, not an insider's discretionary market action. It provides no new information about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: Negligible. The grant does not involve open-market trading.
- Sentiment Indicator: Neutral. The market typically does not react to routine RSU grants.
Additional Context
Transaction Notes
- The filing also disclosed a disposition of 404 shares (Code 'F') on 2025-10-04 at $22.55 per share. This was not a sale but rather shares withheld by the company to satisfy tax obligations related to the vesting of previously issued RSUs.
- The newly awarded 11,405 RSUs vest in three installments, starting one year from the grant date.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
